Jonathan Pruneda, Ph.D., led a study to explore how a form of the common protein ubiquitin is modified during an infection with illness-causing bacteria. With further research, his study's findings could lead to improved care for Parkinson's disease and breast cancer. (OHSU/Christine Torres Hicks)
